Spermidine and spermine exert protective effects within the lung

Area of Science:

• Immunology
• Metabolomics
• Respiratory Medicine

Background:

• Asthma pathogenesis involves environmental factors, metabolism, and immune regulation.
• Protein-derived metabolites' role in lung inflammation is understudied.
• Specific metabolites are recognized to influence respiratory inflammation.

Purpose of the Study:

• Quantify polyamine levels in bronchoalveolar lavages (BALs) from asthma patients and healthy controls.
• Evaluate polyamine impact on inflammatory responses in vitro and in vivo.
• Investigate polyamines as potential biomarkers and therapeutic targets for asthma.

Main Methods:

• Ultra Performance Liquid Chromatography (UPLC) for polyamine quantification in BALs.
• In vitro studies using human peripheral blood mononuclear cells (PBMCs) and dendritic cells (DCs) stimulated with lipopolysaccharide (LPS).
• Murine models of house dust mite (HDM)-induced respiratory allergy, assessing effects of oral polyamine administration.

Main Results:

• Asthma patients showed decreased spermidine and increased cadaverine levels in BALs compared to controls.
• Spermine and spermidine inhibited LPS-induced cytokine secretion from PBMCs and DCs.
• Oral spermine/spermidine modulated HDM-induced inflammation, including cell infiltration, cytokine levels, and epithelial tight junctions in mice.
• Spermidine administration reduced airway hyper-responsiveness in the murine model.

Conclusions:

• Polyamine metabolism, particularly spermidine, is associated with respiratory inflammation in asthma.
• Polyamines demonstrate potential as biomarkers for asthma diagnosis and progression.
• Modulating polyamine pathways represents a promising strategy for novel asthma therapies.